ERIN MEIXNER: Open Payments
NPI 1295401917 · PERRYVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 47 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,258 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $453 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| Janssen Biotech, Inc. | 4 | $77 |
| Madrigal Pharmaceuticals | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: RINVOQ, ENTYVIO, XIFAXAN, TREMFYA, LINZESS, REZDIFFRA, DUPIXENT, SKYRIZI.
Industry payments across MO — which companies pay providers there.
